Summary
Updated Aug 31, 2026
Michael C. Skaff files SEC Form 4 reports at Vivos Therapeutics, Inc. (VVOS). 2 SEC Form 4 filings on record, most recently on 15 July 2026. Most recent open-market trade: bought $414K of VVOS on 2 April 2026. Lifetime open-market purchases: $10.37M. Historical track record: 1/5 stars across 5 tracked purchases.
Recent Transactions
2Every recent SEC Form 4 transaction Michael C. Skaff has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★☆☆☆☆ (1/5) |
| Total purchases tracked | 5 |
| Purchases with forward-return data | 5 |
| 30-day win rate | 0% |
| 90-day win rate | 0% |
| Avg 5-day return | +11.02% |
| Avg 30-day return | -32.19% |
| Avg 90-day return | -58.22% |
| Best 30-day return | -32.19% |
Trading Pattern
InsiderAlpha's records for Michael C. Skaff go back to 2026: 2 primary Form 4 filings, an average of 2.0 per year. The typical open-market purchase is $1.30M (8 buys totaling $10.37M). The largest single buy on record is $2.39M of VVOS in 2026. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Most Active Insiders Right Now
Michael C. Skaff has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- Silver Lake Partners V DE (AIV), L.P. - $165.05M of DELL open-market activity in the last 90 days
- GIC Private Ltd - $158.25M of MDLN open-market activity in the last 90 days
- Sean Lie - $157.48M of CBRS open-market activity in the last 90 days
- John B. Hess - $157.37M of CVX open-market activity in the last 90 days
- Mark Barrocas - $156.00M of SN open-market activity in the last 90 days
- Jack Jiajia Huang - $155.38M of COE open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Michael C. Skaff?
Michael C. Skaff is a corporate insider of Vivos Therapeutics, Inc. (VVOS). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Michael C. Skaff submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Michael C. Skaff been buying or selling stock?
Recorded transactions: 8 open-market purchases ($10.37M) and 0 open-market sales across all tracked filings.
How accurate is Michael C. Skaff's historical track record?
Across 5 tracked purchases, Michael C. Skaff averaged -32.2% avg 30-day return with a 0% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.
Where can I see all of Michael C. Skaff's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Michael C. Skaff and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial